Helical closes $10M seed to turn bio foundation models into systems
3 Articles
3 Articles
Helical closes $10M seed to turn bio foundation models into systems
The Luxembourg-founded startup is already in production with multiple top-20 global pharma companies, including a public collaboration with Pfizer. Its $10M seed round is led by redalpine, with the CEOs of Cohere and HuggingFace among the angel investors. Helical, a London-based pharma AI startup founded by three Luxembourgish childhood friends, has raised $10 million in […] This story continues at The Next Web
Helical raises $10M to bridge the gap between foundation models and drug discovery decisions
Pharma artificial intelligence startup Helical Ltd. announced today that it has raised $10 million in new funding to expand its virtual AI lab platform, which turns biological foundation models into reproducible in-silico drug discovery workflows. Founded in 2024, Helical was built around a specific gap its founders identified as biological foundation models have gained traction […] The post Helical raises $10M to bridge the gap between foundati…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium

